In situ size amplification strategy reduces lymphatic clearance for enhanced arthritis therapy
Abstract Rheumatoid arthritis (RA) is an autoimmune disorder characterized by painful swelling and inflammation, arising from the immune system attacking on healthy cells. However, arthritic sites often experience increased lymph flow, hastening drug clearance and potentially reducing treatment effe...
Saved in:
| Main Authors: | Xianyan Qin, Luhan Zhang, Yang-Bao Miao, Linxi Jiang, Liang Zou, Qin Wang, Yi Shi |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMC
2024-12-01
|
| Series: | Journal of Nanobiotechnology |
| Subjects: | |
| Online Access: | https://doi.org/10.1186/s12951-024-03061-8 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Update of Photodynamic Therapy and Sonodynamic Therapy in Treating Rheumatoid Arthritis
by: Zhao Chenyang, Sun Desheng, Tan Li, Chen Xiangmei
Published: (2025-06-01) -
Targeting the ferroptosis pathway for rheumatoid arthritis: molecular mechanisms and prospects for inhibitor development
by: Zhuoling Wang, et al.
Published: (2025-06-01) -
TREX1 activators: A novel therapeutic strategy for rheumatoid arthritis management via cfDNA clearance
by: Yuping Wang, et al.
Published: (2025-08-01) -
Phytomedicine meets nanotechnology: A cellular approach to rheumatoid arthritis treatment
by: Vikas Shukla, et al.
Published: (2024-12-01) -
Lysosomal targeting of liposomes with acidic pH and Cathepsin B induces protein aggregate clearance
by: Minsol Jeon, et al.
Published: (2025-06-01)